Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BPY2DP (Basic charge Y-linked 2D, pseudogene) is a DNA segment found on the Y chromosome that is categorized as a pseudogene. Pseudogenes such as BPY2DP resemble functional genes but have lost the capacity to code for a functional protein product, typically due to disabling mutations like premature stop codons or frameshifts[1][3][5]. BPY2DP is noncoding, is not transcribed into a functional protein, and plays no direct, defined biological or disease role. Pseudogenes can occasionally be transcribed into RNA or influence gene expression, but no such regulatory or disease-linked function is reported for BPY2DP[1][2][5][7]. Essentially, BPY2DP is a nonfunctional, Y-linked pseudogene and not a therapeutic or biological target. Its abbreviation reflects its full descriptive name, and it holds no role in drug interaction, disease, or molecular targeting[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Basic charge Y-linked 2D, pseudogene (BPY2DP).